Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.xpro.2023.102338
Title: Protocol for identification and validation of IGF2BP1 target genes in pluripotent human embryonic carcinoma cells
Authors: Myint, K 
Chuang, LSH 
Matsuo, J 
Ito, Y 
Keywords: Cancer
Cell Biology
Cell-based Assays
Molecular Biology
Issue Date: 16-Jun-2023
Publisher: Elsevier BV
Citation: Myint, K, Chuang, LSH, Matsuo, J, Ito, Y (2023-06-16). Protocol for identification and validation of IGF2BP1 target genes in pluripotent human embryonic carcinoma cells. STAR Protocols 4 (2) : 102338-. ScholarBank@NUS Repository. https://doi.org/10.1016/j.xpro.2023.102338
Abstract: We present a detailed protocol to identify and validate IGF2BP1 target genes in pluripotent human embryonic carcinoma cells (NTERA-2). We first identify the target genes through RNA-immunoprecipitation (RIP) sequencing. We then validate the identified targets through the use of RIP-qPCR assays, determine the m6A status of target genes by m6A-IP, and perform functional validation by quantifying changes in mRNA or protein expression levels upon knockdown of IGF2BP1 or methyltransferases in NTERA-2. For complete details on the use and execution of this protocol, please refer to Myint et al. (2022).1
Source Title: STAR Protocols
URI: https://scholarbank.nus.edu.sg/handle/10635/248782
ISSN: 2666-1667
DOI: 10.1016/j.xpro.2023.102338
Appears in Collections:Staff Publications
Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Protocol for identification and validation of IGF2BP1 target genes in pluripotent human embryonic carcinoma cells.pdf2.05 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.